SIDE EFFECTS OF COVID-19 VACCINES IN HEALTHCARE WORKERS AND EMPLOYEES AT CAN THO UNIVERSITY OF MEDICINE AND PHARMACY

Van Lam Nguyen1,, Thi Thao Do1, Trieu Viet Nguyen1, Thi Thu Tram Nguyen1, Thi Hau Vo1, Hoai An Tran1, Le Nghia Hiep Huynh1, Ngoc Hoa Bui1
1 Can Tho University of Medicine and Pharmacy

Main Article Content

Abstract

Backgroud: Pandemic caused by the coronavirus in 2019. The major method for preventing Coronavirus infection and transmission is vaccination. Covid - 19 vaccines, though cause a lot of adverse effects. Objectives: to describe the unfavorable reactions that officials and lecturers had after receiving the second dosage of Pfizer and AstraZeneca immunizations and compare the proportion of sides affecte between two vaccines. Materials and methods: A cross sectional study in 167 officials and lecturers at the Can Tho University of Medicine and Pharmacy. Pfizer and AstraZeneca's vaccination side effects as reported in an automated postal survey. the comparison of side effects between vaccinations of the same and different kinds. Use SPSS 20 to carry out Fisher's Exact Test, Chi-Square Test. Results: Results from the second immunization revealed that 91.6% of participants had adverse effects. Shortness of breath (1.2%) had the lowest rate (87.4%), followed by pain at the injection site and adverse effects. Comparing the same/different vaccines at the second injection, there was a statistically significant difference in the frequencies of adverse effects, including pain at the injection site, weariness, and swelling at the injection site. Conclusions: The most frequent adverse effect was pain at the injection site (87.4%). A higher rate of side effects was observed in the group of individuals who initially received a different type of vaccine than who received the same vaccine.

Article Details

References

1. WHO. WHO Coronavirus (COVID-19) Dashboard. 2020. https://covid19.who.int/table.
2. Li H., Liu Z., and Ge J. Scientific research progress of COVID-19/SARS-CoV-2 in the first five months. J Cell Mol Med. 2020. 24(12), 6558-6570, doi: 10.1111/jcmm.15364.
3. Triggle C. R., Bansal D., Ding H., Islam M. M., Farag E., Hadi H. A., et al. A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic. Front Immunol. 2021. 12, 631139, doi: 10.3389/fimmu.2021.631139.
4. Vogel W. H. Infusion reactions: diagnosis, assessment, and management. Clin J Oncol Nurs. 2010. 14(2), E10-21, doi: 10.1188/10.CJON.E10-E21.
5. Menni C., Klaser K., May A., Polidori L., Capdevila J., Louca P., et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis. 2021. 21(7), 939-949, doi: 10.1016/S1473-3099(21)00224-3.
6. Calenic B., Okamura K., Yaegaki K., Tovaru S., Tanaka T., and Imai T. Role of p53-mediated apoptotic pathway in oral lichen planus: Relationship among pro-apoptotic, anti-apoptotic, and keratinocytic markers. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2014. 26(2), 221-227, https://doi.org/10.1016/j.ajoms.2013.06.009.
7. Hatmal M. M., Al-Hatamleh M. A. I., Olaimat A. N., Hatmal M., Alhaj-Qasem D. M., Olaimat T. M., et al. Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects. Vaccines (Basel). 2021. 9(6), 556, doi: 10.3390/vaccines9060556.
8. Agency E. M. AstraZeneca’s COVID-19 Vaccine: EMA Finds Possible Link to Very Rare
Cases of Unusual Blood Clots with Low Blood Platelets. 2021. https://www.ema.europa.eu/en/news/astrazenecas-covid-19-vaccine-ema-finds-possible-linkvery-rare-cases-unusual-blood-clots-low-blood.
10. Carli G., Nichele I., Ruggeri M., Barra S., and Tosetto A. Deep vein thrombosis ( DVT ) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine. Intern Emerg Med. 2021. 16(3), 803-804, doi: 10.1007/s11739-021-02685-0.
11. Alshahrani M. M., and Alqahtani A. Side Effects of Mixing Vaccines against COVID-19 Infection among Saudi Population. Vaccines (Basel). 2022. 10(4), 519, doi: 10.3390/vaccines10040519.
12. Shaw R. H., Stuart A., Greenland M., Liu X., Nguyen Van-Tam J. S., and Snape M. D. Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data. Lancet. 2021. 397(10289), 2043-2046, doi: 10.1016/S0140-6736(21)01115-6.
13. Hillus D., Schwarz T., Tober-Lau P., Vanshylla K., Hastor H., Thibeault C., et al. Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study. Lancet Respir Med. 2021. 9(11), 1255-1265, https://doi.org/10.1016/S2213-2600(21)00357-X.